Overview

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

The purpose is to obtain data on the safety and seizure frequency associated with long-term oral Lacosamide for uncontrolled primary generalized tonic-clonic (PGTC) seizures in subjects with idiopathic generalized Epilepsy. Additionally, to allow subjects who have completed SP0961 (NCT01118949) to continue to receive Lacosamide.

Phase:

Phase 2

Details

Lead Sponsor:

UCB BIOSCIENCES, Inc.

Treatments:

Lacosamide